Two-Year Follow-Up of Impaired Range of Motion in Chronic Fatigue Syndrome.
Rowe, Peter C, Marden, Colleen L, Flaherty, Marissa A K et al. · The Journal of pediatrics · 2018 · DOI
Quick Summary
This study tracked how physical flexibility and movement changed in 53 young people with ME/CFS over two years while they received multimodal therapy. Researchers measured range of motion in 11 different body areas and found that most participants showed significant improvement—the proportion with abnormal movement patterns dropped from 78% to 20%. Importantly, improvements in flexibility were linked with improvements in physical quality of life.
Why It Matters
Many ME/CFS patients experience reduced flexibility and movement limitations that affect daily functioning. This study provides evidence that ROM impairment is not permanent and can improve substantially over time with appropriate treatment, offering hope to patients and demonstrating that physical rehabilitation outcomes may be measurable and clinically meaningful in ME/CFS.
Observed Findings
Proportion of participants with abnormal ROM (score >2) decreased from 78% at baseline to 20% at 24-month follow-up (P<0.001)
Median ROM score improved from 5 to 2 over the 2-year period (P<0.001)
Degree of ROM improvement positively correlated with improvement in physical function subscale of PedsQL (r=0.30; P<0.03)
96% of enrolled participants (53 of 55) completed 24-month follow-up
Mean age at enrollment was 16.5 years, with range 10–23 years
Inferred Conclusions
ROM impairment in young people with ME/CFS is modifiable and tends to improve progressively over 2 years with multimodal therapy
Improvement in range of motion is associated with meaningful improvements in physical quality of life
Longitudinal monitoring of ROM may serve as a useful objective marker of physical improvement in ME/CFS
Remaining Questions
Which specific components of multimodal therapy (if any) drove the ROM improvements, and what is the optimal treatment approach?
Do ROM improvements persist beyond 24 months, or is there risk of deterioration with time?
What This Study Does Not Prove
This study does not prove that any single therapy caused the ROM improvements, since participants received multimodal treatment and there was no control group. The correlation between ROM improvement and quality-of-life gains does not establish causation—both may have improved for independent reasons. The study also does not establish whether these improvements persist long-term beyond 24 months.
Tags
Symptom:Fatigue
Phenotype:Pediatric
Method Flag:PEM Not DefinedWeak Case DefinitionNo Controls
What physiological mechanisms underlie ROM impairment in ME/CFS, and why do some patients improve more than others?
How do ROM changes correlate with objective measures of physical function (e.g., exercise capacity, activity levels) beyond patient-reported quality of life?